Variant report
Variant | esv3351638 |
---|---|
Chromosome Location | chr13:30223202-30225350 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs548037662 | chr13:30223220-30223221 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs112571454 | chr13:30223235-30223236 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573090689 | chr13:30223283-30223284 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79388224 | chr13:30223285-30223286 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148106910 | chr13:30223292-30223293 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192911647 | chr13:30223316-30223317 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs117474991 | chr13:30223337-30223338 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs650480 | chr13:30223352-30223353 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs73154472 | chr13:30223353-30223354 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569761895 | chr13:30223401-30223402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs552464736 | chr13:30223436-30223437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537100758 | chr13:30223469-30223470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140992879 | chr13:30223496-30223497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558479649 | chr13:30223553-30223554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs144947831 | chr13:30223576-30223577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138809024 | chr13:30223655-30223656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs568455377 | chr13:30223801-30223802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs531070652 | chr13:30223872-30223873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74508454 | chr13:30223897-30223898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559633725 | chr13:30223910-30223911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200220386 | chr13:30223920-30223921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375675389 | chr13:30223921-30223922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565580744 | chr13:30223923-30223924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145528154 | chr13:30223932-30223933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs59930632 | chr13:30223948-30223949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs55732071 | chr13:30223950-30223951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs201286166 | chr13:30223960-30223961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1275368 | chr13:30223988-30223989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528219824 | chr13:30224005-30224006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1275367 | chr13:30224008-30224009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs60086398 | chr13:30224031-30224032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555570982 | chr13:30224032-30224033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1275366 | chr13:30224041-30224042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372055911 | chr13:30224065-30224066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs9508520 | chr13:30224127-30224128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs575227883 | chr13:30224134-30224135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544316073 | chr13:30224135-30224136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs541579538 | chr13:30224169-30224170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs181156367 | chr13:30224192-30224193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557295553 | chr13:30224199-30224200 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185707422 | chr13:30224205-30224206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1275365 | chr13:30224211-30224212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs563309870 | chr13:30224213-30224214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs368279464 | chr13:30224214-30224215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577227358 | chr13:30224215-30224216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112354517 | chr13:30224254-30224255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546039225 | chr13:30224288-30224289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559612998 | chr13:30224320-30224321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs386769539 | chr13:30224420-30224421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs111448350 | chr13:30224421-30224422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 20164920 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Malignant glioma | 17146433 | CNVD |
Breast cancer | 17899364 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Peters Plus syndrome | 16909395 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Breast cancer | 20031965 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Ovarian cancer | 19047089 | CNVD |
Alveolar rhabdomyosarcoma | 16790082 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 18632612 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:30220800-30226800 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
2 | chr13:30222400-30229400 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr13:30222800-30232800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
4 | chr13:30222800-30232800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr13:30223000-30223400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
6 | chr13:30223000-30223400 | Active TSS | Duodenum Mucosa | Duodenum |
7 | chr13:30223200-30223400 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
8 | chr13:30224600-30225000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr13:30224600-30225200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |